Status:
UNKNOWN
The Efficacy of Pain Control After Total Hip Replacement Between Ultrasound Guided Supra-inguinal Fascia Iliaca Block and Intrathecal Morphine
Lead Sponsor:
Mahidol University
Conditions:
Total Hip Replacement
Ultrasound Guided Supra-inguinal Fascia Iliaca Block
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Total hip replacement is one of major orthopedic surgery which result in severe postoperative pain especially at first 24 hours. Ultrasound guided regional anesthesia has become a part of multimodal a...
Detailed Description
By using combine ultrasound guided supra-inguinal fascia iliaca block with periarticular infiltration with mutimodal analgesic drugs will have longer duration time to first rescue analgesic drug compa...
Eligibility Criteria
Inclusion
- elective surgery of primary total hip replacement, body weight ≥40kg and BMI ≤35 kg/m2, competence to consent
Exclusion
- contraindication to regional anesthesia, allergy to study drugs, skin infection at supra-inguinal fascia iliaca injection point, neurological deficit affecting the lower extremities, inability to use patient-controlled analgesia, GFR \<50 mL/min
Key Trial Info
Start Date :
December 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT04104204
Start Date
December 3 2019
End Date
December 1 2021
Last Update
February 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj hospital
Bangkok, Thailand, 10700